Age Factors; Animals; Chemiluminescent Measurements; Circadian Rhythm/physiology; Collagen/blood; Collagen Type I; Horses/blood/physiology; Immunosorbent Techniques; Osteocalcin/blood; Peptides/blood; Radioimmunoassay
Abstract :
[en] OBJECTIVE: To evaluate a human assay for quantification of carboxy-terminal cross-linking telopeptide of type I collagen (CTX-I), assess the influence of age on plasma CTX-I concentration, investigate the relationship between plasma CTX-I and serum osteocalcin concentrations, and determine whether concentrations of plasma CTX-I or serum osteocalcin fluctuate in circadian manner in horses. HORSES: 75 clinically normal horses. PROCEDURE: Cross-reactivity between equine serum CTX-I and CTX-I antibodies in an automated electrochemiluminescent sandwich antibody assay (ECLIA) was evaluated via a specificity test (ie, dilution test) and recovery calculation. Serum osteocalcin concentration was measured with an equine-specific osteocalcin radioimmunoassay. To analyze diurnal variations in plasma CTX-I and serum osteocalcin concentrations, blood samples were obtained hourly during a 24-hour period. RESULTS: Results of the dilution test indicated good correlation (r > 0.99) between expected serum CTX-I concentrations and measured serum CTX-I concentrations. The calculated CTX-I recovery was 97.6% to 109.9%. Plasma CTX-I and serum osteocalcin concentrations were correlated. Plasma CTX-I concentration was inversely correlated with age of the horse. No significant circadian variations in plasma CTX-I and serum osteocalcin concentrations were detected. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that the fully automated CTX-I ECLIA can be used for evaluation of plasma and serum samples from horses and may be a useful tool to monitor bone metabolism changes. Horses in this study did not have notable diurnal fluctuations in serum osteocalcin and plasma CTX-I concentrations.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Carstanjen, Bianca
Hoyle, Nicholas R
Gabriel, Annick ; Université de Liège - ULiège > Département de morphologie et pathologie > Anatomie des animaux domestiques
Hars, Olaf
Sandersen, Charlotte ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Département clinique des animaux de compagnie et des équidés
Amory, Hélène ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Médecine interne des équidés
Estberg L, Stover SM, Gardner IA, et al. High-speed exercise history and catastrophic racing fracture in thoroughbreds. Am J Vet Res 1996;57:1549-1555.
Lepage OM, Carstanjen B, Uebelhart D. Noninvasive assessment of equine bone: an update. Vet J 2001;161:10-22.
Christenson RH. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997;30:573-593.
Robey PG, Fisher LW, Young MF, et al. The biochemistry of bone. In: Riggs BL, Melton LJ, eds. Osteoporosis: etiology, diagnosis and management. Raven Press: New York, 198;95-109.
Seibel MJ, Eastell R, Gundberg CM, et al. Biochemical markers of bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. Vol 2. 2nd ed. Academic Press Inc: San Diego, 2002;1543-1571.
Seibel MJ, Woitge HW. Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom 1999;2:299-321.
Delmas PD. The committee of scientific advisors of the international osteoporosis foundation. Bone Marker Nomenclature. Bone 2001;28:575-576.
Delmas PD, Eastell R, Garnero P, et al. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000;6:S2-S17.
Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, et al. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 2000;26:505-511.
Garnero P, Borel O, Delmas PD. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001;47:694-702.
Rosenquist C, Fledelius C, Christgau S, et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998;44:2281-2289.
Risteli J, Elomaa I, Niemi S, et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635-640.
Sassi ML, Eriksen H, Risteli L, et al. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 2000; 26:367-373.
Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A 1975;72:3925-3929.
Hauschka PV, Carr SA. Calcium-dependent, alpha-helical structure in osteocalcin. Biochemistry 1982;21:2538-2547.
Eastell R, Delmas PD, Hodgson SF, et al. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 1988;67:741-748.
Chen JT, Hosoda K, Hasumi K, et al. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Miner Res 1996; 11:1784-1792.
Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993;25:385-393.
Boskey AL, Gadaleta S, Gundberg C, et al. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998; 23:187-196.
Carstanjen B, Sulon J, Banga-Mboko H, et al. Development and validation of a specific radioimmunoassay for equine osteocalcin. Domest Anim Endocrinol 2003;24:31-41.
Kumar MS, Deodhar SD. An improved radioimmunoassay of serum gastrin using commercial kit. Clin Chim Acta 1975; 61:191-197.
Price JS, Jackson B, Eastell R, et al. Age related changes in biochemical markers of bone metabolism in horses. Equine Vet J 1995; 27:201-207.
Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984;137:380-388.
Black A, Schoknecht PA, Ralston SL, et al. Diurnal variation and age differences in the biochemical markers of bone turnover in horses. J Anim Sci 1999;77:75-83.
Hoekstra KE, Nielsen BD, Orth MW, et al. Comparison of bone mineral content and biochemical markers of bone metabolism in stall- vs. pasture-reared horses. Equine Vet J 1999;30:601-604.
Caron JP, Peters TL, Hauptman JG, et al. Serum concentrations of keratan sulfate, osteocalcin, and pyridinoline crosslinks after oral administration of glucosamine to standardbred horses during race training. Am J Vet Res 2002;63:1106-1110.
Patterson-Allen P, Brautigam CE, Grindeland RE, et al. A specific radioimmunoassay for osteocalcin with advantageous species crossreactivity. Anal Biochem 1982;120:1-7.
Christgau S, Rosenquist C, Alexandersen P, et al. Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem 1998;44:2290-2300.
Price PA, Williamson MK, Lothringer JW. Origin of a vitamin-K dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981;256:12760-12766.
Pagani F, Bonetti O, Stefini F, et al. Evaluation of a fully automated assay to measure C-telopeptide of type-I collagen in serum. Clin Chem Lab Med 2000;38:1111-1113.
Chiappe A, Gonzales G, Fradinger E, et al. Influence of age and sex in serum osteocalcin levels in thoroughbred horses. Arch Physiol Biochem 1999;107:50-54.
Lepage OM, Marcoux M, Tremblay A. Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age. Can J Vet Res 1990; 54:223-226.
Mäenpää PE, Pirskanen A, Koskinen E. Biochemical indicators of bone formation in foals after transfer from pasture to stables for the winter months. Am J Vet Res 1988;49:1990-1992.
Bonde M, Garnero P, Fledelius C, et al. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 1997;12:1028-1034.
Fledelius C, Johnsen AH, Cloos PA, et al. Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerized Asp-Gly sequence within the C-terminal telopeptide (αl) region. J Biol Chem 1997;272:9755-9763.
Simmons DJ, Nichols G. Diurnal periodicity in the metabolic activity of bone tissue. Am J Physiol 1966;210:411-418.
Simmons DJ. Daily rhythm of S32 incorporation into epiphyseal cartilage in mice. Experientia 1968;24:363-364.
Liesegang A, Reutter R, Sassi ML, et al. Diurnal variation in concentrations of various markers of bone metabolism in dogs. Am J Vet Res 1999;60:949-953.
Hassager C, Risteli J, Risteli L, et al. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992;7:1307-1311.
Lepage OM, DesCoteaux L, Marcoux M, et al. Circadian rhythms of osteocalcin in equine serum. Correlation with alkaline phosphatase, calcium, phosphate and total protein levels. Can J Vet Res 1991;55:5-10.
Gundberg CM, Markowitz ME, Mizruchi M, et al. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985;60:736-739.
Simmons DJ, Whiteside LA, Whitson SW. Biorhythmic profiles in the rat skeleton. Metab Bone Dis Rel Res 1979;2:49-64.
Jubiz W, Canterbury JM, Reiss E, et al. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels. J Clin Invest 1972;51:2040-2046.
Hope E, Johnston SD, Hegstad RL, et al. Effects of sample collection and handling on concentration of osteocalcin in equine serum. Am J Vet Res 1993;54:1017-1020.
Geor R, Hope E, Lauper L, et al. Effect of glucocorticoids on serum osteocalcin concentration in horses. Am J Vet Res 1995; 56:1201-1205.
Fletcher KL, Topliff DR, Cooper SR, et al. Influence of age and sex on serum osteocalcin concentrations in horses at weaning and during physical conditioning. J Equine Vet Sci 2000;20:124-126.
Corlett SC, Couch M, Care AD, et al. Measurement of plasma osteocalcin in sheep: assessment of circadian variation, the effects of age and nutritional status and the response to perturbation of the adrenocortical axis. Exp Physiol 1990;75:515-527.
Wichers M, Schmidt E, Bidlingmaier F, et al. Diurnal rhythm of CrossLaps in human serum. Clin Chem 1999;45:1858-1860.
Aoshima H, Kushida K, Takahashi M, et al. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone 1998;22:73-78.
Clowes JA, Hannon RA, Yap TS, et al. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 2002;30:886-890.
Cole DE, Gundberg CM, Stirk LJ, et al. Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism. J Clin Endocrinol Metab 1987;65:290-294.
Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991;28:287-335.
Carstanjen B, Wattiez R, Amory H, et al. Isolement et characterisation de l'ostéocalcine équine. Ann Med Vét 2002;146:31-38.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
